David P. Hochman
Chief Executive Officer and Chairperson, Director · Orchestra BioMed Holdings, Inc.
- 2024
- Sep 11, 2026
- 18
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David P. Hochman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Darren Sherman - $364K in OBIO purchases and sales in the last 12 months
- Eric S. Fain - $83K in OBIO purchases and sales in the last 12 months
- Jason Aryeh - $37K in OBIO purchases and sales in the last 12 months
- RTW INVESTMENTS, LP - $132 in OBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David P. Hochman?
David P. Hochman is a corporate insider, tracked as Chief Executive Officer and Chairperson, Director of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha holds 18 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David P. Hochman submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has David P. Hochman been buying or selling stock?
Recorded transactions: 9 open-market purchases ($262K) and 0 open-market sales across all tracked filings.
